Observational studies: A review of study designs, challenges and strategies to reduce confounding

International Journal of Clinical Practice

Volumn 63, Issue 5, 2009, Pages 691-697

  Lu, C Y ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL RESEARCH; ARTICLE; CASE CONTROL STUDY; CASE REPORT; CLINICAL PRACTICE; CLINICAL RESEARCH; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EPIDEMIOLOGICAL DATA; MEDICAL DECISION MAKING; METHODOLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VALIDITY;

CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC METHODS; MEDICAL RECORDS; OBSERVATION; RESEARCH DESIGN;

EID: 64149091320     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02056.x     Document Type: Article

References (21)

1. Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 1997 6 (Suppl. 3 S51 9.
2. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996 312 : 1215 8.
3. Mamdani M, Juurlink DN, Lee DS et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004 363 : 1751 6.
4. Ray WA, Stein CM, Daugherty JR et al. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002 360 : 1071 3.
5. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008 61 : 344 9.
6. Goldacre M. The role of cohort studies in medical research. Pharmacoepidemiol Drug Saf 2001 10 : 5 11.
7. Rochon PA, Gurwitz JH, Sykora K et al. Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ 2005 330 : 895 7.
8. Breslow N. Design and analysis of case-control studies. Annu Rev Public Health 1982 3 : 29 54.
9. Etminan M. Pharmacoepidemiology II: the nested case-control study - a novel approach in pharmacoepidemiologic research. Pharmacotherapy 2004 24 : 1105 9.
10. Farrington CP. Re: "Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design". Am J Epidemiol 2004 159 : 717 8 author reply 8-20.
11. Farrington P, Pugh S, Colville A et al. A new method for active surveillance of adverse events from diphtheria-tetanus-pertussis and measles-mumps-rubella vaccines. Lancet 1995 345 : 567 9.
12. Hubbard R, Farrington P, Smith C et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 2003 158 : 77 84.
13. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006 25 : 1768 97.
14. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991 133 : 144 53.
15. Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 1995 16 : 61 81.
16. Psaty BM, Koepsell TD, Lin D et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999 47 : 749 54.
17. Mamdani M, Sykora K, Li P et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005 330 : 960 2.
18. Normand SL, Sykora K, Li P et al. Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ 2005 330 : 1021 3.
19. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984 79 : 516 24.
20. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000 29 : 722 9.
21. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006 17 : 268 75.